pharmaphorum

APRIL 1, 2021

They go into bioinformatics”. There’s a lot of bioinformatics know-how and talent and a lot of good scientists who would like to better understand biology but don’t have the money to do it in wet settings. They go into bioinformatics.”. So what do they do? So, what do they do? About the interviewees.

Bioinformatics 123

Bioinformatics Drugs Development Scientist 123

Drug Discovery World podcast

MARCH 25, 2022

The articles are called “The benefits of bioinformatics in genomics sequencing” and “LIMs vs ELNs – what does your lab need?”, Dr Kim’s appointment comes at a time of sustained growth for the company, which is benefitting from the rapidly expanding sequencing market. The second and third article are in two parts.

Bioinformatics 52

Bioinformatics Genome Genomics Drugs 52

XTalks

APRIL 21, 2023

Biotech company Ultima Genomics has joined forces with Genome Insight, a bioinformatics-based biomedicine company, to overcome the caveat of cost and quality in WGS. Ultima Genomics will provide their high-throughput NGS instrument platform, the UG 100, and Genome Insight will provide the bioinformatics platform for data analysis.

Genome 97

Genome Genomics Bioinformatics Genetics 97

pharmaphorum

JUNE 10, 2022

Pharma’s digital initiatives now routinely enable new channels that educate and market to patients, physician engagement that is more efficient and effective, and novel payment mechanisms and distribution models that improve access to therapies. Pharma’s evolving role in patient care. About BrightInsight.

Marketing 133

Marketing Engineer Bioinformatics Regulation 133

XTalks

JULY 19, 2021

“We successfully brought a medical-grade test, analogs of which are billed by the big players anywhere from $1,500 – $10,000, to a price point more accessible to the consumer market at $249.”. Bisignano added that, “It is time we finally made a medical-grade genetic test available as a proactive, preventative tool.

Genetics 98

Genetics Genome Genomics Gene 98

pharmaphorum

JANUARY 19, 2022

This will provide researchers with the option to analyse their data without the need to learn code, which can be a challenging requirement for those not au fait with bioinformatics. Its mission is to introduce and accelerate the adoption of groundbreaking life science research tools to their markets.

RNA 72

RNA Research Life Science Bioinformatics 72

Rethinking Clinical Trials

FEBRUARY 28, 2024

The global decentralized clinical trial market is expected to grow at a compound annual growth rate of 30.1%             Speakers Adrian Hernandez, MD Executive Director, Duke Clinical Research Institute Vice Dean, Duke University School of Medicine Christopher J. from 2021 to 2026.

Clinical Trials 113

Clinical Trials Clinical Trials Trials Clinical Research 113

The Pharma Data

OCTOBER 20, 2020

21, 2020 /PRNewswire/ — United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will report its third quarter 2020 financial results before the market opens on Wednesday, October 28, 2020. SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , Eastern Time.

Marketing 40

Marketing Bioinformatics Containment Branding 40

pharmaphorum

OCTOBER 20, 2021

That aspect will be of key interest to Eisai, which along with Biogen brought the first potentially disease-modifying therapy for Alzheimer’s – amyloid-targeting antibody Aduhelm (aducanumab) – to the market in the US, albeit on the back of controversial data.

Trials 78

Trials Genome Genomics Bioinformatics 78

pharmaphorum

JANUARY 11, 2023

The research solutions cluster came second, with 15% of the total (just over $5 billion) – marked by a $300 million third round for Chinese bioinformatics firm Enzymaster – with patient solutions at 11% ($3.6 It also scored highest for clinical evidence, and that was reflected in its 17% share of the funding pot, valued at $5.4

Bioinformatics 75

Bioinformatics Clinical Trials Clinical Trials Production 75

XTalks

SEPTEMBER 28, 2020

The Resolution ctDx Assay is based on Resolution Bioscience’s patented cell-free DNA (cfDNA) analysis platform, which includes proprietary targeted capture next-generation sequencing (NGS) biochemistry and tightly coupled, cloud-based bioinformatics.

Gene 105

Gene DNA Life Science Genotype 105

Roots Analysis

AUGUST 28, 2022

Recent advances in multi-omics approaches, including genomics, transcriptomics, proteomics, metabolomics, cytometry and imaging, in combination with bioinformatics and biostatistics, have been translated into several popular bioanalytical platforms, such as next-generation sequencing (NGS), single-cell analysis, flow cytometry and mass spectrometry.

Genome 52

Genome Genomics RNA Genome Project 52

pharmaphorum

APRIL 15, 2021

Global innovation initiatives also help Astellas identify appropriate pathways for accelerated development and review of new therapies across markets. We anticipate a revolution in digital solutions, such as artificial intelligence, bioinformatics and companion diagnostics.”. In principle, this goes beyond medicines.

Development 76

Development Manufacturing Production Bioinformatics 76

The Pharma Data

MARCH 20, 2021

In connection with research programs covering yeast fermentation, fungal fermentation, lactic acid fermentation, bio catalysis and genomic tools including bioinformatics, the center is always on the lookout for the latest developments in inline measurement technology. Scope of possible application . Use of the CO2 sensor InPro 5000 .

Genome 52

Genome Genomics Bioinformatics Production 52

The Pharma Data

SEPTEMBER 11, 2021

This precise and rational approach to library fabrication combined with sophisticated bioinformatics and software expertise expedites antibody discovery by decreasing risk, increasing speed, and lowering the failure rate for antibody therapeutic development. About Twist Bioscience Corporation. Source link: [link].

Antibody 52

Antibody DNA Containment Manufacturing 52

The Pharma Data

JULY 27, 2021

Teneobio’s discovery platform, TeneoSeek, comprises genetically engineered animals (UniRat® and OmniFlic®), next-generation sequencing, bioinformatics and high-throughput vector assembly technologies. About Teneobio Teneobio, Inc. Our business may be impacted by government investigations, litigation and product liability claims.

Production 52

Production Antibody Sales Development 52

The Pharma Data

DECEMBER 16, 2020

This includes Evotec’s data analysis platform “PanHunter”, a proprietary, integrated, user-centred bioinformatics platform which facilitates the analysis of PanOmics data integrated with other metadata sets. 0)40.56081-255, gabriele.hansen@evotec.com. 0)40.56081-775, volker.braun@evotec.com.

Protein 40

Protein Bioinformatics Containment Drugs 40

Roots Analysis

AUGUST 15, 2024

This article explores the role of molecular diagnostics in early cancer detection, highlighting the benefits and future prospects in the oncology molecular diagnostics market. A growing sub-segment of the overall market is oncology molecular diagnostics market, which is helping fill the unmet need for early diagnosis.

Marketing 40

Marketing Genetics Genome Genomics 40

The Pharma Data

OCTOBER 27, 2020

The decrease in Adcirca revenues was driven by continued erosion of market share due to generic competition. Sales and marketing. Cash, cash equivalents, and marketable investments. Cost of product sales. Dollar Change. .

Production 40

Production Sales Licensing Licensing 40

World of DTC Marketing

FEBRUARY 10, 2022

Of the 16 states with adult obesity rates 35 percent or higher, 10 — Alabama, Arkansas, Indiana, Kentucky, Louisiana, Mississippi, Ohio, Oklahoma, Tennessee and Texas — rank in the top 20 for age-adjusted per capita covid death rates, according to Bioinformatics CRO, a consulting firm. Washington Post. But what is it we are eating?

Bioinformatics 197

Bioinformatics Nurses Packaging Packaging 197

pharmaphorum

MAY 27, 2022

data processing systems that support bioinformatics modelling) and digital record systems (e.g. Digital technologies can cover a broad range of applications, and include mobile health (mHealth) tools (e.g. video consultations), health data analytics (e.g. digital applications, also referred to as “apps”, that function as patient diaries).

Clinical Trials 80

Clinical Trials Clinical Trials Trials Packaging 80

XTalks

NOVEMBER 7, 2022

Optimal methods for bioinformatic analysis are still needed. These two tests may be making their way onto the market soon, potentially changing the paradigm in cancer screening. There is a high risk of false positives and false negatives (variant allele frequencies [VAFs] at frequencies <0.5 percent show less reliability).

Clinical Trials 98

Clinical Trials Clinical Trials Trials FDA Approval 98

The Pharma Data

DECEMBER 8, 2020

Orphan drug designation is the first step in receiving orphan drug exclusivity following approval, which confers seven years of market exclusivity for the relevant indication. The granting of an orphan drug designation request does not alter the standard regulatory requirements and process for obtaining marketing approval.

Drugs 40

Drugs FDA Approval Marketing Containment 40

XTalks

DECEMBER 13, 2023

Moreover, it has submitted global marketing authorization applications for mRNA-1345, a vaccine designed to prevent RSV-associated lower respiratory tract disease (RSV-LRTD) and acute respiratory disease (ARD), supported by favorable data from a predefined interim analysis. vaccine, mRNA-1273.815.

Genetics 111

Genetics Vaccination Vaccine DNA 111

Roots Analysis

JANUARY 27, 2025

The recent advancements in the field of protein expression, coupled with the launch of novel expression systems have emerged as the key drivers for the growing adoption of protein expression solutions in the overall pharma market. Want additional details on the market? Access our Protein Expression Market Report.

Protein 40

Protein Reagent Marketing Gene 40

The Pharma Data

JANUARY 10, 2021

I actually think neuroscience is going to heat up in 2021,” said Ben Zeskind , co-founder and CEO of Immuneering , which is using bioinformatics and computational biology to develop new drugs in this space, along with oncology and immuno-oncology. Moving on From the Amyloid Hypothesis. “I The future of cancer prevention?

Vaccination 52

Vaccination Vaccine Regulation Drugs 52

The Pharma Data

SEPTEMBER 1, 2020

Presentation Topic: Biomarkers and Bioinformatics. Neurofilament light chain concentration predicts risk of relapse in participants with relapsing multiple sclerosis in phase 3 ozanimod trials. Author: Harris. Presentation Number: P0118. Author: Healy. Presentation Number: P1010. No forward-looking statement can be guaranteed.

Trials 52

Trials Clinical Trials Clinical Trials Vaccination 52